What dose of Spironolactone and Kidneys is used at eGFR 30–44?

At 30–44 mL/min/1.73m² (or CrCl 30–50), the recommended dose of Spironolactone and Kidneys is: 12.5-25 mg once daily, with monitoring.

Is Spironolactone and Kidneys safe in kidney disease at eGFR 30–44?

Requires potassium ≤5.0 at start. Watch closely — hyperkalemia is the main risk. This table is dosing guidance for planning — the final dose is confirmed by your prescriber, and kidney function and the drug's own monitoring requirements are rechecked regularly.

What should I check while taking Spironolactone and Kidneys at eGFR 30–44?

Follow the drug's label monitoring — typically kidney function (eGFR/creatinine), and for many drugs potassium, drug levels, or blood counts as applicable. Report any new symptoms such as weakness, irregular heartbeat, or unusual side effects to your doctor.

What dose of Spironolactone and Kidneys is used at eGFR 30–44?

At 30–44 mL/min/1.73m² (or CrCl 30–50), the recommended dose of Spironolactone and Kidneys is: 12.5-25 mg once daily, with monitoring.

Is Spironolactone and Kidneys safe in kidney disease at eGFR 30–44?

Requires potassium ≤5.0 at start. Watch closely — hyperkalemia is the main risk. This table is dosing guidance for planning — the final dose is confirmed by your prescriber, and kidney function and the drug's own monitoring requirements are rechecked regularly.

What should I check while taking Spironolactone and Kidneys at eGFR 30–44?

Follow the drug's label monitoring — typically kidney function (eGFR/creatinine), and for many drugs potassium, drug levels, or blood counts as applicable. Report any new symptoms such as weakness, irregular heartbeat, or unusual side effects to your doctor.

Renal Dosing Guide

Spironolactone and Kidneys Dosing at eGFR 30–44

Aldactone • Mineralocorticoid receptor antagonist (potassium-sparing diuretic) • Kidney function: 30–44 mL/min/1.73m² (or CrCl 30–50)

The recommended dose of Spironolactone and Kidneys at 30–44 mL/min/1.73m² (or CrCl 30–50) — with monitoring notes for kidney disease and dialysis.

Recommended dose at eGFR 30–44

12.5-25 mg once daily, with monitoring.

Requires potassium ≤5.0 at start. Watch closely — hyperkalemia is the main risk.

Dosing at Other Kidney Function Levels

Spironolactone and Kidneys at eGFR ≥45

≥45 mL/min/1.73m² (or CrCl >50)

View dose

Spironolactone and Kidneys at eGFR 15–29

15–29 mL/min/1.73m² (or CrCl 15–29)

View dose

Spironolactone and Kidneys at eGFR <15

<15 mL/min/1.73m² (not on dialysis)

View dose

Spironolactone and Kidneys at On dialysis

Hemodialysis or peritoneal dialysis

View dose

How dosing is decided

Doses in this guide follow drug labels and renal-dosing references at each eGFR/CrCl level. Always confirm with your prescriber and pharmacy — your specific dose depends on other medications, conditions, and lab results.

Full Spironolactone and Kidneys kidney guide

Monitoring reminder

Spironolactone and Kidneys has its own monitoring requirements (eGFR, potassium, drug levels, or blood counts). These become more frequent as kidney function falls. Report unusual weakness, irregular heartbeat, or new side effects promptly.

Interactive drug-dosing tool